Novartis Vaccines & Diagnostics is classified as operating in the Biological Product Manufacturing industry, NAICS Code 325414.
Trademark Applications
Trademark applications show the products and services that Novartis Vaccines & Diagnostics is developing and marketing.
Novartis Vaccines & Diagnostics doesn't have any recent trademark applications, indicating Novartis Vaccines & Diagnostics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
PROLEUKIN Pharmaceutical preparations for the treatment of oncological diseases and disorders
12/16/2010
PROCLEIX KITS COMPRISING DIAGNOSTIC REAGENTS AND NUCLEIC ACIDS FOR IN VITRO MEDICAL DIAGNOSTIC USE
10/12/1999
See all trademarks and details in the Full Report.
Market Share of Novartis Vaccines & Diagnostics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Novartis Vaccines & Diagnostics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Novartis Vaccines & Diagnostics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Novartis Vaccines & Diagnostics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.